Hematologic DiseasesBone Marrow TransplantationHematologic NeoplasmsLeukemiaBone MarrowHematopoietic Stem Cell TransplantationTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationHematopoiesisRecurrenceCombined Modality TherapyRadiation ChimeraMice, Inbred C57BLLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationLeukemia, Myeloid, AcuteImmunosuppressive AgentsRemission InductionTreatment OutcomeGraft RejectionHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingTime FactorsBone Marrow NeoplasmsTransplantation ImmunologyGraft vs Host ReactionLeukemia, MyeloidImmunosuppressionLymphocyte DepletionStem Cell TransplantationLeukocyte TransfusionLymphoma, Non-HodgkinHeart TransplantationAcute DiseaseSevere Combined ImmunodeficiencyChimeraColony-Forming Units AssayT-LymphocytesHLA AntigensSurvival AnalysisMyelodysplastic SyndromesRetrospective StudiesLung TransplantationCyclosporineActuarial AnalysisBone DensityLymphocyte TransfusionNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsCarmustineOrgan TransplantationPancytopeniaGraft vs Tumor EffectCell DifferentiationGraft vs Leukemia EffectFollow-Up StudiesCytarabineLeukocyte CountSurvival RateCytomegalovirus InfectionsBone ResorptionSpleenGranulocyte Colony-Stimulating FactorMelphalanMice, Inbred BALB CDisease-Free SurvivalEtoposideFlow CytometryLymphomaMultiple MyelomaCells, CulturedFatal OutcomeAntigens, CD34Hodgkin DiseaseMice, KnockoutPrognosisInfectionCell TransplantationGranulocytesCord Blood Stem Cell Transplantation